CompoSecure Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
06 Mar
  • FY 2024 Net Sales up 8% to $420.6 million — In-Line with Preliminary Results on February 10, 2025
  • FY 2024 Cash Flow from Operations up 24% to $129.6 million and Free Cash Flow up 62% to $84.9 million
  • Company Expects Mid-Single Digit Growth for 2025 Net Sales and Adjusted EBITDA
  • Completed Spin-Off of Resolute Holdings on February 28, 2025

SOMERSET, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced its operating results for the fourth quarter and full year ended December 31, 2024.

Jon Wilk, President and CEO of CompoSecure, commented: “2024 was a foundational year for CompoSecure, marked by high-single digit Net Sales growth, robust Free Cash Flow, international momentum and unique product innovations. We also made significant progress in fortifying our balance sheet in 2024, reducing net debt by 60% to $120 million.

During the fourth quarter, we made strategic investments in the CompoSecure Operating System (COS) to deliver consistent excellence across the organization and focused on planting seeds to drive both organic and inorganic growth. For 2025, we will accelerate the adoption of COS and expect to build sales momentum throughout the year. Notably, we closed out the year with our first quarter of positive net contribution from Arculus in Q4, and continue to expect Arculus to be net positive for full year 2025.”

Dave Cote, CompoSecure’s Executive Chairman, added: “As we enter 2025, I am excited about the opportunities ahead for our business. The spin-off of Resolute Holdings marks an important step in our evolution as we position the business for accelerated growth and diversification of revenue. We are committed to cultivating a culture of high performance, driving efficiency through our CompoSecure Operating System, reigniting organic growth, and delivering on accretive M&A.”

Financial Highlights (Q4 2024 vs. Q4 2023 )

  • Net Sales: Net Sales increased 1% to $100.9 million compared to $99.9 million.
  • Gross Profit: Gross Profit was $52.5 million or 52.1% of Net Sales, compared to $52.9 million or 52.9%.
  • Net Income(Loss)/EPS: Net Income/(Loss) was $(48.4) million compared to $31.0 million. The decrease was driven by an improvement to the Company’s stock price during the quarter, which led to a change in the fair value of warrant liabilities, earnout consideration liability and derivative liability. Net Income/(Loss) per share attributable to Class A common shareholders was $(0.53) (Basic) and $(0.53) (Diluted), compared to $0.17 (Basic) and $0.17 (Diluted) in the year-ago period.
  • Adjusted Net Income/Adjusted EPS: Adjusted Net Income (a non-GAAP measure) increased 8% to $24.7 million compared to $22.8 million in the year-ago period. Adjusted EPS (a non-GAAP measure) was $0.27 (Basic) and $0.20 (Diluted) compared to $0.29 (Basic) and $0.24 (Diluted) in the year-ago period.
  • Adjusted EBITDA: Adjusted EBITDA (a non-GAAP measure) decreased 10% to $33.6 million compared to $37.2 million primarily driven by investment in our M&A capabilities.

See reconciliation of non-GAAP measures shown in table below.

FY 2024 Financial Highlights (vs. FY 2023)

  • Net Sales: Net Sales increased 8% to $420.6 million compared to $390.6 million. The increase was primarily driven by continued domestic growth of 7%, and international growth of 11%.
  • Gross Profit: Gross Profit was $219.2 million or 52.1% of Net Sales, compared to $209.1 million or 53.5%. The decline in gross margin was primarily due to lower production efficiencies from new and innovative card constructions, as well as the impact of inflationary pressure on wages and materials.
  • Net Income(Loss)/EPS: Net Income was $(83.2) million compared to $112.5 million. The decrease was driven by an improvement to the Company’s stock price which led to changes to the fair value of warrant liabilities, earnout consideration liability and derivative liability. Net Income per share attributable to Class A common stockholders was $(1.22) (Basic) and $(1.22) (Diluted), compared to $1.03 (Basic) and $0.96 (Diluted) in the year-ago period.
  • Adjusted Net Income/Adjusted EPS: Adjusted Net Income (a non-GAAP measure) increased 11% to $98.2 million compared to $88.1 million in the year-ago period. Adjusted EPS (a non-GAAP measure) was $1.17 (Basic) and $0.95 (Diluted) compared to $1.12 (Basic) and $0.92 (Diluted) in the year-ago period.
  • Adjusted EBITDA: Adjusted EBITDA (a non-GAAP measure) increased 4% to $151.4 million compared to $145.0 million.

Liquidity and Capital Structure

Balance Sheet: At December 31, 2024, CompoSecure had $77.5 million of cash and cash equivalents and $197.5 million of total debt (resulting in net debt of $120 million). This compares to cash and cash equivalents of $41.2 million and total debt of $340.3 million at December 31, 2023. The improvement was driven by strong Free Cash Flow generation as well as the conversion into equity of $130 million of exchangeable notes during the fourth quarter. CompoSecure’s secured debt leverage ratio was $1.25x at December 31, 2024 compared to 1.39x at December 31, 2023.

Full Year Highlights

  • Appointed new Executive Chairman, David Cote, and expanded Board of Directors
  • Spun off Resolute Holdings, which entered into a management agreement with our wholly owned subsidiary, CompoSecure Holdings L.L.C.
  • Metal card program highlights include: Delta Reserve, Robinhood Gold, Citi/American Airlines, Barclays (Europe), JetBlue, HSBC, Capital on Tap, US Bank Smartly, Wells Fargo Expedia Onekey, and American Express White Gold
  • Award recognition: Received 9 company awards including the Banking Tech Visionary CEO award; three 2024 International Card Manufactures Awards (ICMA) Awards (Best Metal Cards, Best Environmentally-Friendly Cards, and Best Secure Payment Cards)

2025 Financial Outlook

For FY 2025, CompoSecure expects mid-single digit growth in both Net Sales and Adjusted EBITDA with sales momentum building through the year and includes payment of the new Resolute Holdings management fee in 2025 and 2024 (on a pro forma basis).

Conference Call

CompoSecure will host a conference call and live audio webcast today at 5:00 p.m. Eastern Time to discuss its financial and operational results, followed by a question-and-answer period.

Date: Wednesday, March 5, 2025
Time: 5:00 p.m. Eastern Time
Dial-in registration link
Live webcast registration link


If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

A live webcast and replay of the conference call will be available on the investor relations section of CompoSecure’s website at https://ir.composecure.com/news-events/events.

About CompoSecure

Founded in 2000, CompoSecure (Nasdaq: CMPO) is a technology partner to market leaders, fintech’s and consumers enabling trust for millions of people around the globe. The company combines elegance, simplicity and security to deliver exceptional experiences and peace of mind in the physical and digital world. CompoSecure’s innovative payment card technology and metal cards with Arculus security and authentication capabilities deliver unique, premium branded experiences, enable people to access and use their financial and digital assets, and ensure trust at the point of a transaction. For more information, please visit www.CompoSecure.com and www.GetArculus.com.

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management. Although CompoSecure believes that its plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, CompoSecure cannot assure you that it will achieve or realize these plans, intentions, or expectations. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning CompoSecure’s possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. In some instances, these statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements which speak only as of the date hereof. You should understand that the following important factors, among others, could affect CompoSecure’s future results and could cause those results or other outcomes to differ materially from those expressed or implied in CompoSecure’s forward-looking statements: the possibility that the spin-off will not achieve its intended benefits; the ability of the Company to successfully execute its plans and strategies, including with respect to M&A; the possibility of disruption, including changes to existing business relationships, disputes, litigation or unanticipated costs in connection with the spin-off; uncertainty of the expected financial performance of CompoSecure or Resolute Holdings following completion of the spin-off; evolving legal, regulatory and tax regimes; actions by third parties, including government agencies; the ability of CompoSecure to diversify its business and customer base and to achieve enhancements in organic growth and operational efficiency, including for any future acquired companies; the ability of CompoSecure to create value for its shareholders and generate robust free cash flow; the ability of CompoSecure to grow and manage growth profitably, maintain relationships with customers, compete within its industry and retain its key employees; the possibility that CompoSecure may be adversely impacted by other global economic, business, competitive and/or other factors; the outcome of any legal proceedings that may be instituted against CompoSecure or others; future exchange and interest rates; and other risks and uncertainties, including those under “Risk Factors” in filings that have been made or will be made with the Securities and Exchange Commission. CompoSecure undertakes no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Use of Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures that are not prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and that may be different from non-GAAP financial measures used by other companies. CompoSecure believes EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Free Cash Flow and Net Debt are useful to investors in evaluating CompoSecure’s financial performance. CompoSecure uses these measures internally to establish forecasts, budgets and operational goals to manage and monitor its business, as well as evaluate its underlying historical performance and/or to measure incentive compensation, as we believe that these non-GAAP financial measures depict the true performance of the business by encompassing only relevant and controllable events, enabling CompoSecure to evaluate and plan more effectively for the future. Due to the forward-looking nature of the financial guidance included above, specific quantification of the charges excluded from the non-GAAP financial measures included in such financial guidance, including with respect to depreciation, amortization, interest, and taxes, that would be required to reconcile the non GAAP financial measures included in such financial guidance to GAAP measures are not available, so it is not feasible to provide accurate forecasted non-GAAP reconciliations without unreasonable effort. Consequently, no disclosure of estimated comparable GAAP measures is included, and no reconciliation of the forward-looking non-GAAP financial measures is included. In addition, CompoSecure’s debt agreements contain covenants that use a variation of these measures for purposes of determining debt covenant compliance. CompoSecure believes that investors should have access to the same set of tools that its management uses in analyzing operating results. EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Free Cash Flow and Net Debt should not be considered as measures of financial performance under U.S. GAAP, and the items excluded from EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Free Cash Flow and Net Debt are significant components in understanding and assessing CompoSecure’s financial performance. Accordingly, these key business metrics have limitations as an analytical tool. They should not be considered as an alternative to net income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flows from operating activities as a measure of CompoSecure’s liquidity and may be different from similarly titled non-GAAP measures used by other companies. Please refer to the information included in this press release for the reconciliation of GAAP measures to these non-GAAP measures.

Corporate Contact
Anthony Piniella
Head of Communications, CompoSecure
(917) 208-7724
apiniella@composecure.com



Investor Relations Contact
Sean Mansouri, CFA
Elevate IR
(720) 330-2829
CMPO@elevate-ir.



 
Condensed Consolidated Balance Sheet Data
(in thousands)
 
    December 31,
2024
  December 31,
2023
    Unaudited    
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents   $ 77,461     $ 41,216  
Accounts receivable     47,449       40,488  
Inventories, net     44,833       52,540  
Prepaid expenses and other current assets     4,159       5,133  
Total current assets     173,902       139,377  
         
Property and equipment, net     23,448       25,212  
Right-of-use asset – operating leases     5,404       7,473  
Deferred tax asset     264,815       23,697  
Derivative asset – interest rate swap     2,749       5,258  
Deposits and other assets     3,600       24  
Total assets   $ 473,918     $ 201,041  
         
LIABILITIES AND STOCKHOLDERS' DEFICIT        
CURRENT LIABILITIES        
Accrued expenses     14,682       11,986  
Accounts payable     11,544       5,193  
Commission payable     2,563       4,429  
Bonus payable     8,466       5,616  
Current portion of long-term debt     11,250       10,313  
Current portion of lease liabilities – operating leases     2,113       1,948  
Current portion of earnout consideration liability     20,533       60  
Current portion of tax receivable agreement liability     5,171       1,425  
Total current liabilities     76,322       40,970  
         
Long-term debt, net of deferred finance costs     184,389       198,331  
Convertible notes           127,832  
Derivative liability – convertible notes redemption make-whole provision           425  
Warrant liability     104,231       8,294  
Lease liabilities – operating leases     3,888       6,220  
Tax receivable agreement liability     248,534       23,949  
Earnout consideration liability           793  
Total liabilities     617,364       406,814  
         
Commitments and contingencies (Note 15)        
         
Redeemable non-controlling interest           596,587  
         
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding.            
Class A common stock, $0.0001 par value; 250,000,000 shares authorized, 100,462,844 and 19,415,123 shares issued and outstanding as of December 31, 2024 and 2023, respectively     10       2  
Class B common stock, $0.0001 par value; 75,000,000 shares authorized 0 shares and 59,958,422 shares issued and outstanding as of December 31, 2024 and 2023, respectively           6  
Additional paid-in-capital     361,379       39,466  
Accumulated other comprehensive income     2,543       4,991  
Accumulated deficit     (507,378 )     (846,825 )
Total stockholders' deficit   $ (143,446 )   $ (802,360 )
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)   $ 473,918     $ 201,041  
Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
 
    Three months ended December 31,   Twelve months ended December 31,
      2024       2023       2024       2023  
Net sales   $ 100,859     $ 99,900     $ 420,571     $ 390,629  
Operating expenses:                
Cost of sales     48,325       47,005       201,344       181,547  
Selling, general and administrative expenses     36,932       22,368       111,605       89,995  
Total operating expenses     85,257       69,373       312,949       271,542  
                 
Income from operations     15,602       30,527       107,622       119,087  
                 
Total other income (expense), net     (61,824 )     4,397       (188,597 )     (2,011 )
(Loss) income before income taxes     (46,222 )     34,924       (80,975 )     117,076  
Income tax (expense)     (2,136 )     (3,901 )     (2,187 )     (4,556 )
Net (loss) income   $ (48,358 )   $ 31,023     $ (83,162 )   $ 112,520  
                 
Net (loss) income attributable to redeemable non-controlling interests   $     $ 27,730     $ (29,443 )   $ 93,281  
Net (loss) income attributable to CompoSecure, Inc.   $ (48,358 )   $ 3,293     $ (53,719 )   $ 19,239  
                 
Net (loss) income per share attributable to Class A common stockholders – basic   $ (0.53 )   $ 0.17     $ (1.22 )   $ 1.03  
Net (loss) income per share attributable to Class A common stockholders – diluted   $ (0.53 )   $ 0.17     $ (1.22 )   $ 0.96  
                 
Weighted average shares used to compute net (loss) income per share attributable to Class A common stockholders – basic (in thousands)     91,371       19,375       44,012       18,661  
Weighted average shares used to compute net (loss) income per share attributable to Class A common stockholders – diluted (in thousands)     91,371       19,375       44,012       35,312  
Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
 
    Twelve months ended December 31,
      2024       2023  
Cash flows from operating activities:        
Net (loss) income   $ (83,162 )   $ 112,520  
Adjustments to reconcile net income to net cash provided by operating activities        
Depreciation and amortization     9,174       8,387  
Stock-based compensation expense     21,235       17,562  
Inventory reserve     (294 )     (1,182 )
Amortization of deferred financing costs     1,155       1,546  
Loss on extinguishment of debt     148        
Revaluation of earnout consideration liability     76,305       (14,237 )
Revaluation of warrant liability     95,937       (8,047 )
Change in fair value of derivative liability     (425 )     139  
Deferred tax expense     (2,469 )     2,667  
Changes in assets and liabilities        
Accounts receivable     (6,961 )     (3,216 )
Inventories     8,001       (8,984 )
Prepaid expenses and other assets     974       (1,309 )
Accounts payable     6,351       (1,934 )
Accrued expenses     2,696       1,833  
Other liabilities     888       (1,433 )
Net cash provided by operating activities     129,553       104,312  
         
Cash flows from investing activities:        
Purchase of property and equipment     (7,410 )     (10,944 )
Investment in SAFE     (1,500 )      
Capitalized software expenditures     (1,035 )      
Net cash used in investing activities     (9,945 )     (10,944 )
         
Cash flows from financing activities:        
Proceeds from employee stock purchase plan and exercise of options     4,998       1,196  
Payments for taxes related to net share settlement of equity awards     (8,994 )     (3,126 )
Payments for taxes related to net share settlement of Earnouts     (3,789 )      
Payment of term loan     (12,813 )     (22,810 )
Payment of tax receivable agreement liability     (1,303 )     (2,436 )
Deferred finance costs related to debt modification     (2,104 )     (256 )
Tax distributions to non-controlling members     (34,863 )     (38,362 )
Special Distribution to non-controlling members     (15,573 )      
Dividend to Class A shareholders     (8,922 )      
Net cash used in financing activities     (83,363 )     (65,794 )
         
Net increase (decrease) in cash and cash equivalents     36,245       27,574  
         
Cash and cash equivalents, beginning of year   $ 41,216     $ 13,642  
         
Cash and cash equivalents, end of year   $ 77,461     $ 41,216  
         
Supplementary disclosure of cash flow information:        
Cash paid for interest expense     20,608       27,247  
Cash paid for income taxes     4,820       2,760  
Supplemental disclosure of non-cash financing activities:        
Derivative asset – interest rate swap     (2,448 )     (3,292 )
Non-GAAP Adjusted EBITDA Reconciliation
(in thousands)
(unaudited)
 
    Three months ended December 31,   Twelve months ended December 31,
      2024       2023       2024       2023  
    (in thousands)
Net (loss) income   $ (48,358 )   $ 31,023     $ (83,162 )   $ 112,520  
Add:                
Depreciation and amortization     2,242       2,138       9,174       8,387  
Interest expense, net (1)     (147 )     5,801       16,780       24,156  
Income tax expense     2,136       3,901       2,187       4,556  
EBITDA   $ (44,127 )   $ 42,863     $ (55,021 )   $ 149,619  
Stock-based compensation expense     5,966       4,510       21,235       17,562  
Mark-to-market adjustments, net (2)     61,971       (10,198 )     171,817       (22,145 )
September Resolute deal expenses                 2,726        
Secondary offering transaction costs                 586        
Debt refinance costs                 225        
Additional earnout costs     3,680             3,680        
Spin-off costs     6,119             6,119        
Adjusted EBITDA   $ 33,609     $ 37,175     $ 151,367     $ 145,036  
 
(1) Includes amortization of deferred financing cost for the three and twelve months ended December 31, 2024 and 2023, respectively.
(2) Includes the changes in fair value of warrant liability, derivative liabilities and earnout consideration liability for the three and twelve months ended December 31, 2024 and 2023, respectively.
Non-GAAP Adjusted EPS Reconciliation
(in thousands)
(unaudited)
 
    Three months ended December 31,   Twelve months ended December 31,
      2024       2023       2024       2023  
    (in thousands) except per share amounts
Basic:                
Net (loss) income   $ (48,358 )   $ 31,023     $ (83,162 )   $ 112,520  
Add: provision for income taxes     2,136       3,901       2,187       4,556  
(Loss) income before income taxes     (46,222 )     34,924       (80,975 )     117,076  
Add (less): mark-to-market adjustments (1)     61,971       (10,198 )     171,817       (22,145 )
Add: stock-based compensation     5,966       4,510       21,235       17,562  
Add: September Resolute deal expenses                 2,726        
Add: secondary offering transaction costs                 586        
Add: debt refinance costs                 225        
Add: additional earnout costs     3,680             3,680        
Add: spin-off costs     6,119             6,119        
Adjustments total     31,514       29,236       125,413       112,493  
Income tax expense (2)     6,845       6,399       27,240       24,433  
Adjusted net income   $ 24,669     $ 22,837     $ 98,173     $ 88,060  
Common shares outstanding used in computing net income per share, basic:                
Class A and Class B common shares (3)     91,371       79,334       83,834       78,619  
Adjusted net income per share – basic     0.27       0.29       1.17       1.12  
                 
Diluted:                
Adjusted net income     24,669       22,837       98,173       88,060  
Add: Interest on convertible notes net of tax     (2,110 )     1,781       3,238       7,123  
Adjusted net income used in computing net income per share, diluted (5)     22,559       24,618       101,411       95,183  
Common shares outstanding used in computing net income per share, diluted:                
Warrants (4)     8,094       8,094       8,094       8,094  
Exchangeable Notes (5)     5,795       13,000       11,629       13,000  
Equity awards     4,901       2,988       3,411       3,651  
Total shares outstanding used in computing net income per share – diluted (5)     110,161       103,416       106,968       103,364  
Adjusted net income per share – diluted   $ 0.20     $ 0.24     $ 0.95     $ 0.92  
 
1) Includes the changes in fair value of warrant liability, make-whole provision of Exchangeable Notes, and earnout consideration liability.
2) Calculated using the Company's blended tax rate
3) Assumes both Class A and Class B shares participate in earnings and are outstanding at the end of the period.There were no Class B shares outstanding as of December 31, 2024.
4) Assumes treasury stock method, valuation at assumed fair market value of $18.00.
5) The Exchangeable Notes were included through the application of the "if-converted" method. Interest related to the Exchangeable Notes, net of tax was excluded from net income.
Non-GAAP Free Cash Flow
(in thousands)
(unaudited)
 
    Twelve months ended December 31,
      2024       2023  
Net cash provided by operating activities   $ 129,553     $ 104,312  
Purchase of property and equipment     (7,410 )     (10,944 )
Capitalized software expenditures     (1,035 )      
Tax distributions to non-controlling members     (34,863 )     (38,362 )
Payment of tax receivable agreement liability     (1,303 )     (2,436 )
Free cash flow   $ 84,942     $ 52,570  

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10